Sharon Peacock is an Honorary Senior Research Fellow in the Department of Medicine, and currently divides her research group and activities between the Wellcome Trust Sanger Institute where she is an honorary faculty member, and the Cambridge Biomedical Campus. Her research group focuses on the use of microbial whole genome sequencing in diagnostic and public health microbiology and its application to outbreak investigation and antimicrobial prescribing. Her group are also undertaking a series of genomic studies to identify reservoirs of antimicrobial resistance in healthcare facilities, farms, the food chain and the environment. She receives funding from the Medical Research Council through a UKCRC (UK Clinical Research Collaboration) Translational Infection Research Initiative Consortium Grant, from the Department of Health and Wellcome Trust through a Health Innovation Challenge Fund Award, and from the MRC-DBT for the development of a partnership between Cambridge and the National Institute of Research on tuberculosis in Chennai, India. Professor Peacock is Director of the Bloomsbury Research Institute, a Fellow of the Academy of Medical Sciences, and was awarded a CBE for services to medical microbiology in 2015.
Tong SY, Holden MT, Nickerson EK, Cooper BS, Köser CU, Cori A, Jombart T, Cauchemez S, Fraser C, Wuthiekanun V, Thaipadungpanit J, Hongsuwan M, Day NP, Limmathurotsakul D, Parkhill J, Peacock SJ. Genome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureusin a high transmission setting. Genome Res. 2015; 25:111-8.
Chetchotisakd P, Chierakul W, Chaowagul W, Anunnatsiri S, Phimda K, Mootsikapun P, Chaisuksant S, Pilaikul J, Thinkhamrop B, Piphitaporn S, Susaengrat W, Toondee C, Wongrattanacheewin S, Wuthiekanun V, Thaipadungpanit J, Day NP, Limmathurotsakul D, Peacock SJ. Trimethoprim-sulphamethoxazole versus trimethoprim-sulphamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383:807-814.
Köser CU, Bryant JM, Becq J, Török ME, Ellington MJ, Marti-Renom MA, Carmichael AJ, Parkhill J, Smith GP, Peacock SJ. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. New Engl J Med. 2013;369:290-292.
Harris SR, Cartwright EJP, Török ME, Holden MT, Brown NM, Ogilvy-Stuart AL, Ellington MJ, Quail MA, Bentley SD, Parkhill J, Peacock SJ. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis. 2013;13:130-6.
Köser CU, Holden MTG, Ellington MJ, Cartwright EJP, Brown NM, Ogilvy-Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, Sanders M, Enright MC, Dougan G, Bentley SD, Parkhill J, Fraser LJ, Betley JR, Schulz-Trieglaff OB, Smith GP, Peacock SJ. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. New Engl J Med. 2012;363:2267-2275.